Risk stratification for sudden cardiac death: current status and challenges for the future

HJJ Wellens, PJ Schwartz, FW Lindemans… - European heart …, 2014 - academic.oup.com
Sudden cardiac death (SCD) remains a daunting problem. It is a major public health issue
for several reasons: from its prevalence (20% of total mortality in the industrialized world) to …

Clinical neurocardiology defining the value of neuroscience‐based cardiovascular therapeutics

K Shivkumar, OA Ajijola, I Anand… - The Journal of …, 2016 - Wiley Online Library
The autonomic nervous system regulates all aspects of normal cardiac function, and is
recognized to play a critical role in the pathophysiology of many cardiovascular diseases. As …

Myocardial fibrosis as a predictor of sudden death in patients with coronary artery disease

A Zegard, O Okafor, J De Bono, M Kalla… - Journal of the American …, 2021 - jacc.org
Background The “gray zone” of myocardial fibrosis (GZF) on cardiovascular magnetic
resonance may be a substrate for ventricular arrhythmias (VAs). Objectives The purpose of …

Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study

KA Gatzoulis, D Tsiachris, P Arsenos… - European heart …, 2019 - academic.oup.com
Aims Sudden cardiac death (SCD) annual incidence is 0.6–1% in post-myocardial infarction
(MI) patients with left ventricular ejection fraction (LVEF)≥ 40%. No recommendations for …

Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death?

N Dagres, G Hindricks - European heart journal, 2013 - academic.oup.com
Patients who have experienced a myocardial infarction (MI) are at increased risk of sudden
cardiac death (SCD). With the advent of implantable cardioverter-defibrillators (ICDs) …

JCS/JHRS 2022 guideline on diagnosis and risk assessment of arrhythmia

B Takase, T Ikeda, W Shimizu, H Abe, T Aiba… - Circulation …, 2024 - jstage.jst.go.jp
Sinus node dysfunction may be either transient (reversible/physiological) due to the
involvement of the autonomic nervous system or pharmaceuticals, or chronic due to …

Applying competing risks regression models: an overview

B Haller, G Schmidt, K Ulm - Lifetime data analysis, 2013 - Springer
In many clinical research applications the time to occurrence of one event of interest, that
may be obscured by another—so called competing—event, is investigated. Specific …

Reperfused vs. nonreperfused myocardial infarction: when to use which model

ML Lindsey, LE de Castro Brás… - American Journal …, 2021 - journals.physiology.org
There is a lack of understanding in the cardiac remodeling field regarding the use of
nonreperfused myocardial infarction (MI) and reperfused MI in animal models of MI. This …

Change in left ventricular ejection fraction following first myocardial infarction and outcome

DS Chew, H Heikki, G Schmidt, KM Kavanagh… - JACC: Clinical …, 2018 - jacc.org
Objectives: This study hypothesizes that a lack of left ventricular ejection fraction (LVEF)
recovery after myocardial infarction (MI) would be associated with a poor outcome …

From evidence-based medicine to digital twin technology for predicting ventricular tachycardia in ischaemic cardiomyopathy

AGW de Lepper, CMA Buck… - Journal of the …, 2022 - royalsocietypublishing.org
Survivors of myocardial infarction are at risk of life-threatening ventricular tachycardias (VTs)
later in their lives. Current guidelines for implantable cardioverter defibrillators (ICDs) …